London-based femtech Flo Health secures more than €180 million Series C and achieves unicorn status

Flo Health raises record $200m for period tracking app and becomes Europe’s first femtech unicorn

Flo Health Receives More than $200M Investment from General Atlantic

Flo Health, a London-based femtech company, has raised over €180 million in a Series C investment from General Atlantic, pushing its valuation beyond $1 billion and achieving unicorn status. This investment will support Flo's expansion into new user segments like perimenopause and menopause, enhance its tech-driven health insights, and pursue strategic growth opportunities. Flo intends to invest in top-tier talent across its global offices and leverage General Atlantic's expertise in scaling consumer technology, healthcare, and subscription business models. With nearly 70 million monthly active users and close to 5 million paid subscribers, Flo's gross bookings are expected to exceed $200 million in 2024.

Flo Health Reaches Unicorn Status with €180 Million Series C Funding

Flo Health is a London-based femtech company that offers a popular women's health app, providing cycle and ovulation tracking, health insights, and a private digital discussion community focused on health and wellness. It boasts over 120 doctors and health experts on its platform and aims to support women at every stage of their health journey, from menstruation to menopause.

A London-based femtech company offering a women's health app with cycle and ovulation tracking, health insights, and a private community focused on wellness.

a year ago

Flo Health Reaches Unicorn Status with €180 Million Series C Funding

Covered on